Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P GALMICHE

Showing results (271-280 of 296) with videos related to

Pageof 30
Sort By:
Digestive Diseases and Sciences|March 1, 1993
Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis TrialistsA L Blum, B Adami, M H Bouzo, et al.
Journal De Pharmacologie|January 1, 1986
[Methods for the evaluation of the action of drugs on digestive tract motility and gastric acid secretion]J P Galmiche, J P Isal, J C Delchier, et al.
Gastroenterologie Clinique Et Biologique|August 1, 1987
[Campylobacter pylori and gastric mucosa: histological and bacteriological study and preliminary results of an epidemiological survey in the area of Nantes]M F Le Bodic, P Barré, C Freland, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2017
The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgeryL Mastracci, R Fiocca, C Engström, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2017
Editorial: the diminishing returns of normalisation of the oesophageal mucosa-Authors' replyL Mastracci, R Fiocca, C Engstrom, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2015
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studiesS E Attwood, C Ell, J P Galmiche, et al.
Gut|November 22, 2008
Pathological lesions in colonic biopsies during Parkinson's diseaseT Lebouvier, T Chaumette, P Damier, et al.
Gut|July 14, 1999
Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancerA Jarry, G Vallette, E Cassagnau, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 21, 2006
Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathwayM Neunlist, P Aubert, S Bonnaud, et al.
Gastroenterology|February 1, 1993
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)J P Gendre, J Y Mary, C Florent, et al.
Pageof 30

Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Digestive Diseases and Sciences|March 1, 1993
Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis TrialistsA L Blum, B Adami, M H Bouzo, et al.
Journal De Pharmacologie|January 1, 1986
[Methods for the evaluation of the action of drugs on digestive tract motility and gastric acid secretion]J P Galmiche, J P Isal, J C Delchier, et al.
Gastroenterologie Clinique Et Biologique|August 1, 1987
[Campylobacter pylori and gastric mucosa: histological and bacteriological study and preliminary results of an epidemiological survey in the area of Nantes]M F Le Bodic, P Barré, C Freland, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2017
The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgeryL Mastracci, R Fiocca, C Engström, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2017
Editorial: the diminishing returns of normalisation of the oesophageal mucosa-Authors' replyL Mastracci, R Fiocca, C Engstrom, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2015
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studiesS E Attwood, C Ell, J P Galmiche, et al.
Gut|November 22, 2008
Pathological lesions in colonic biopsies during Parkinson's diseaseT Lebouvier, T Chaumette, P Damier, et al.
Gut|July 14, 1999
Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancerA Jarry, G Vallette, E Cassagnau, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 21, 2006
Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathwayM Neunlist, P Aubert, S Bonnaud, et al.
Gastroenterology|February 1, 1993
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)J P Gendre, J Y Mary, C Florent, et al.
Pageof 30